Pittenger & Anderson Inc’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.45M Sell
29,639
-193
-0.6% -$42.8K 0.26% 89
2025
Q4
$6.82M Buy
29,832
+1,110
+4% +$253K 0.26% 84
2025
Q3
$6.65M Buy
28,722
+839
+3% +$171K 0.24% 87
2025
Q2
$5.18M Buy
27,883
+853
+3% +$159K 0.19% 101
2025
Q1
$5.66M Sell
27,030
-224
-0.8% -$43.5K 0.21% 93
2024
Q4
$4.84M Buy
27,254
+320
+1% +$58.8K 0.18% 104
2024
Q3
$5.32M Buy
26,934
+20
+0.1% +$3.73K 0.2% 98
2024
Q2
$4.62M Buy
26,914
+360
+1% +$59.6K 0.19% 97
2024
Q1
$4.84M Buy
26,554
+6,249
+31% +$1.08M 0.2% 99
2023
Q4
$3.15M Buy
20,305
+10,976
+118% +$1.6M 0.14% 120
2023
Q3
$1.39M Buy
9,329
+35
+0.4% +$5.14K 0.07% 136
2023
Q2
$1.25M Sell
9,294
-103
-1% -$15.1K 0.06% 136
2023
Q1
$1.5M Buy
9,397
+113
+1% +$17.3K 0.08% 134
2022
Q4
$1.5M Buy
9,284
+1,394
+18% +$214K 0.08% 133
2022
Q3
$1.06M Buy
7,890
+3,032
+62% +$435K 0.06% 133
2022
Q2
$744K Buy
4,858
+2,212
+84% +$338K 0.04% 144
2022
Q1
$429K Buy
2,646
+5
+0.2% +$726 0.02% 168
2021
Q4
$358K Buy
2,641
+1,273
+93% +$150K 0.02% 181
2021
Q3
$148K Buy
1,368
+586
+75% +$67K 0.01% 217
2021
Q2
$88K Buy
782
+82
+12% +$9.23K ﹤0.01% 237
2021
Q1
$76K Hold
700
﹤0.01% 243
2020
Q4
$75K Sell
700
-500
-42% -$48K ﹤0.01% 238
2020
Q3
$105K Sell
1,200
-300
-20% -$28.2K 0.01% 222
2020
Q2
$147K Sell
1,500
-250
-14% -$22K 0.01% 204
2020
Q1
$133K Sell
1,750
-815
-32% -$69.4K 0.01% 202
2019
Q4
$227K Sell
2,565
-100
-4% -$8.3K 0.02% 209
2019
Q3
$202K Sell
2,665
-2,585
-49% -$177K 0.01% 213
2019
Q2
$382K Sell
5,250
-4,680
-47% -$368K 0.03% 192
2019
Q1
$800K Sell
9,930
-155
-2% -$12.7K 0.06% 171
2018
Q4
$930K Sell
10,085
-16,915
-63% -$1.49M 0.09% 162
2018
Q3
$2.55M Sell
27,000
-175
-0.6% -$16.6K 0.2% 122
2018
Q2
$2.52M Buy
27,175
+14,060
+107% +$1.37M 0.22% 117
2018
Q1
$1.24M Buy
13,115
+2,955
+29% +$325K 0.11% 167
2017
Q4
$983K Buy
10,160
+300
+3% +$28.3K 0.09% 175
2017
Q3
$876K Sell
9,860
-75
-0.8% -$5.71K 0.08% 172
2017
Q2
$720K Sell
9,935
-165
-2% -$11.1K 0.07% 179
2017
Q1
$658K Sell
10,100
-2,185
-18% -$137K 0.07% 180
2016
Q4
$769K Buy
12,285
+258
+2% +$15.7K 0.08% 179
2016
Q3
$759K Sell
12,027
-1,621
-12% -$105K 0.08% 180
2016
Q2
$845K Sell
13,648
-2,802
-17% -$171K 0.09% 177
2016
Q1
$940K Sell
16,450
-55
-0.3% -$3.07K 0.11% 158
2015
Q4
$977K Sell
16,505
-17,255
-51% -$994K 0.12% 160
2015
Q3
$1.86M Buy
33,760
+1,825
+6% +$119K 0.25% 105
2015
Q2
$2.15M Buy
31,935
+625
+2% +$40.8K 0.28% 102
2015
Q1
$1.83M Buy
31,310
+4,965
+19% +$300K 0.24% 106
2014
Q4
$1.72M Buy
26,345
+11,625
+79% +$733K 0.23% 111
2014
Q3
$850K Sell
14,720
-150
-1% -$8.33K 0.12% 147
2014
Q2
$839K Buy
14,870
+520
+4% +$27.3K 0.12% 152
2014
Q1
$738K Sell
14,350
-25
-0.2% -$1.26K 0.1% 184
2013
Q4
$759K Sell
14,375
-1,700
-11% -$83.6K 0.11% 175
2013
Q3
$719K Buy
16,075
+165
+1% +$7.31K 0.11% 160
2013
Q2
$658K Buy
+15,910
New +$696K 0.11% 161

Other funds holding ABBV